Explore This Research Award in CaptureIQ
Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.
Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- Minnesota HealthSolutions Corporation
- Proposal award date
- 2020-09-01
- Contract end date
- 2021-08-31
- UEI
- G34WKGPA1M73
- Solicitation number
- PA18-573
- Topic code
- NHLBI
Research abstract
Project Summary/Abstract
Minnesota HealthSolutions Corporation (MHS) and Children’s Hospital Los Angeles (CHLA) propose the
development and validation of a novel system for creating custom-fit respiratory interface appliances for the
purpose of improving non-invasive ventilation (NIV) for infants and children in the intensive care unit (ICU).
Technology advancements in NIV have improved outcomes for critically ill patients, but unfortunately, most
neonates and children do not achieve the full benefits of NIV, particularly bi-level ventilation, because they are
unable to effectively synchronize breaths with the non-invasive ventilator. This is because pediatric NIV patient
interface appliances often have significant air leakage, which, when combined with the fact that children
generate smaller changes in airway flow, prevents the ventilator from reliably sensing patient effort. The
resulting ventilator breaths are asynchronous with patient effort, leading to ineffective ventilation, higher patient
effort of breathing, and worsening lung injury. To overcome excessive leakage and inadequate triggering,
clinicians often tighten interfaces, resulting in skin breakdown and pressure ulcers. NIV related pressure ulcers
are becoming amongst the most common complications in intensive care units. The lack of effective NIV leads
to higher rates of intubation in neonates and young children, with unnecessary exposure to medications which
harm the developing mind, longer ICU lengths of stay, and iatrogenic complications such as infection, ventilator
induced diaphragm dysfunction, and post-ICU impairment in quality of life. Ventilator manufacturers are
searching for solutions to this problem because many previously developed products have not gained
widescale commercial use since they are invasive or have substantial technical limitations when applied to the
infant or neonate. The proposed project will develop and evaluate an innovative system for rapid in-hospital
production of custom-fit NIV respiratory interfaces.Project Narrative
Minnesota HealthSolutions Corporation and Children’s Hospital Los Angeles propose the development and
validation of a novel methodology for improving non-invasive ventilation (NIV) for infants and children in the
intensive care unit (ICU). This method will overcome major limitations of currently-available noninvasive
ventilator face-worn interface appliances when they are used on small infants and children and will lead to
higher success rates of NIV for infants and children. Improved NIV success rates will result in reduced
intubation in neonates and young children, with reduced exposure to medications which harm the developing
mind, shorter ICU lengths of stay, and fewer iatrogenic complications such as infection, ventilator induced
diaphragm dysfunction and post-ICU impairment in quality of life.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
Research funding history
66 SBIR/STTR records share this UEI (2007–2025). Reported award amounts total $44,761,119. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services, Department of Education, National Science Foundation
Agency intelligence
Department of Health and Human Services
Back to SBIR/STTR Research Awards